(202) 599-8435

Third Party Opinion

WSJ: Governments Exploit Overdose Epidemic To Pad Their Budgets

The editorial board of The Wall Street Journal writes that state and local governments suing prescription opioid manufacturers have so far failed to show that the defendants’ alleged...
Posted on Aug 01, 2017
, By

Person with Pain Shares View from Other Side of Opioid Overdose Epidemic

A person with persistent pain offers a different perspective on the opioid overdose epidemic, explaining how it affects individuals who rely on pain medicine to function daily. While much needed...
Posted on Jul 28, 2017
, By

Sales of Naltrexone Skyrocket with Little Evidence To Support Its Use

Not a single published trial has compared long-acting naltrexone to methadone or buprenorphine for the treatment of opioid use disorder. Long-acting naltrexone’s appeal is largely its physical...
Posted on Jul 13, 2017
, By

Barthwell: Science, Not Stigma, Must Underlie Policy

In this KevinMD op-ed, Dr. Andrea Barthwell, CLAAD co-founder and CEO of Two Dreams, along with Dr. Genie Bailey, ASAM physician, urges policy makers to look to science, not stigma, in addressing...
Posted on Jun 08, 2017
, By

Mandating ADFs for Canadian Prescription Opioids Could Reduce Societal Costs

The Canadian Health Policy Institute (CHPI) has published a study which estimates that if all prescription opioids in Canada were abuse deterrent formulations (ADFs), societal costs in the form...
Posted on May 30, 2017
, By

New Report Would Perpetuate the Opioid Overdose Epidemic

A new report by the Institute for Clinical and Economic Review (ICER) incorrectly claims that abuse-deterrent opioids provide neither financial nor societal benefits. The report focuses on how...
Posted on May 15, 2017
, By

Anti-Opioid Effort Will Not Be Effective Until Implementation of Broader Effort

A big anti-opioid push could be a politically viable step to take on the opioid overdose epidemic, but the effort will not be effective unless it is part of a broader effort of social and...
Posted on Apr 04, 2017
, By

Allowing Imported Drugs Could Be Dangerous

Some members of Congress want to open up the pharmaceutical market to imported medicines, ignoring the potential outcome Maine faced when it did the same thing four years ago. In 2013, Maine...
Posted on Mar 01, 2017
, By

Proposed Legislation Would Help Terminal Patients Get Past the FDA Blockade

Sen. Ron Johnson recently introduced “right-to-try” legislation, which allows a terminal patient to ask a drug maker to provide a treatment that hasn’t won U.S. Food and Drug Administration (FDA)...
Posted on Feb 27, 2017
, By